EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.4.99.4 | Carcinoma, Squamous Cell |
11585423 |
Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
3
0 |
| 2.4.99.4 | Carcinoma, Squamous Cell |
19418726 |
Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia. |
causal interaction
unassigned |
3
0 |
| 2.4.99.4 | Hypertension, Pulmonary |
14705225 |
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in peripheral blood mononuclear cells in systemic sclerosis. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
4
0 |
| 2.4.99.4 | Infections |
16790783 |
Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 2.4.99.4 | Leukemia |
8298305 |
Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase. |
causal interaction
unassigned |
2
0 |
| 2.4.99.4 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
1997166 |
Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells. |
causal interaction
unassigned |
3
0 |
| 2.4.99.4 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
8220157 |
Role of aberrant sialylation of chronic myeloid leukemia granulocytes on binding and signal transduction by chemotactic peptides and colony stimulating factors. |
causal interaction
unassigned |
1
0 |
| 2.4.99.4 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
8298305 |
Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase. |
causal interaction
unassigned |
2
0 |
| 2.4.99.4 | Leukemia, Myeloid, Acute |
8298305 |
Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase. |
causal interaction
unassigned |
2
0 |
| 2.4.99.4 | Leukemia, Myeloid, Acute |
24953795 |
Effect of ST3GAL 4 and FUT 7 on sialyl Lewis X synthesis and multidrug resistance in human acute myeloid leukemia. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
1
3
2 |
